
@article{ref1,
title="Notes from the field: Counterfeit percocet-related overdose cluster - Georgia, june 2017",
journal="MMWR: Morbidity and mortality weekly report",
year="2017",
author="Edison, Laura and Erickson, Amber and Smith, Sasha and Lopez, Gaylord and Hon, Stephanie and King, Alexandra and Nydam, Nancy and O'Neal, J. Patrick and Drenzek, Cherie",
volume="66",
number="41",
pages="1119-1120",
abstract="<p>On June 5, 2017, a Georgia North-Central Health District emergency department (ED) notified the Georgia Poison Center of six opioid overdoses and one death during the previous day. All patients had severe respiratory depression, loss of consciousness, or both, and some required high naloxone doses and mechanical ventilation. Two patients reported taking one or two pills that they believed to be Percocet, purchased without a prescription, on the street.  The Georgia Poison Center notified area hospitals and a Georgia Department of Public Health (GDPH) epidemiologist, who informed partners, including 1) health district epidemiologists, who worked with hospitals; 2) the Georgia Bureau of Investigation, which performed drug testing; 3) the High Intensity Drug Trafficking Area office, which notified law enforcement; 4) local coroners, who reported related deaths to GDPH; and 5) the GDPH Office of Emergency Medical Services (EMS), which notified EMS providers and the medical community. A coordinated communication effort led to two multiagency press conferences on June 6 to notify the public about the presence of the dangerous counterfeit pills.  A counterfeit Percocet cluster case was defined as 1) an opioid toxidrome (i.e., with central nervous system depression, respiratory depression, and pupillary miosis) requiring resuscitation, ventilation, naloxone, or all three; 2) a history of purchasing street pills; and 3) ingestion of as few as one or two pills, resulting in disproportionately severe central nervous system, respiratory, or cardiovascular depression occurring in a person evaluated by EMS or at an ED since June 1, 2017 (1). During June 6–13, EMS providers and EDs reported possible cases daily, and district epidemiologists reviewed medical records to determine whether patients met the case definition. Concomitant syndromic surveillance was conducted by reviewing Georgia statewide ED admission data received daily, using a text-search for drug overdose syndrome. This surveillance was used to determine whether the cluster extended beyond the initially identified area. Local law enforcement personnel delivered pills obtained from one patient to the Georgia Bureau of Investigation crime laboratory for chemical analysis...</p> <p>Language: en</p>",
language="en",
issn="0149-2195",
doi="10.15585/mmwr.mm6641a6",
url="http://dx.doi.org/10.15585/mmwr.mm6641a6"
}